NAV
14.59(0.85%)Fund Size (CR)
₹491.85Expense Ratio
0.67Scheme Type
Active FundValue Research
Min. investment
₹500Minimum Additional Investment
₹500Minimum SIP Investment
₹100Minimum Withdrawal
₹500Exit Load
1%Return Since Launch
19.70%
Basic Details
Scheme Manager
Ramesh Mantri
Bench Mark
BSE Healthcare TRI
Type
OPEN
Lumpsum Returns
| Period Invested For | ₹10,000 Invested on | Latest Value | Absolute Returns | Annualised Returns | Category Avg | Rank within Category |
|---|---|---|---|---|---|---|
| 1 Week | 18 February 2026 | 10113.94 | 1.14% | - | -0.75% | 79/978 |
| 1 Month | 23 January 2026 | 10723.34 | 7.23% | - | 3.84% | 199/964 |
| 3 Month | 25 November 2025 | 9991.71 | -0.08% | - | -0.59% | 464/940 |
| 6 Month | 25 August 2025 | 9982.06 | -0.18% | - | 1.38% | 551/916 |
| 1 Year | 25 February 2025 | 11733.84 | 17.34% | 17.34% | 15.94% | 359/840 |
| 3 Year | - | - | - | - | - | -/- |
| 5 Year | - | - | - | - | - | -/- |
| Since Inception | 6 February 2024 | 14469.00 | 44.69% | 19.70% | 11.39% | 120/987 |
Note: Lumpsum Returns since Inception Date.
SIP Returns
| Period Invested For | ₹10,000 Invested on | Investments | Latest Value | Absolute Returns | Annualised Returns |
|---|---|---|---|---|---|
| 1 Year | 3 March 2025 | 1,20,000 | 128236.14 | 6.86% | 6.86% |
| 3 Year | - | - | - | - | - |
| 5 Year | - | - | - | - | - |
| 10 Year | - | - | - | - | - |
Note: SIP Returns since Inception Date.
Tax Treatment
If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 10%, if your total long term capital gain exceeds 1 lakh. Any cess/surcharge is not included.If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 15%. Any cess/surcharge is not included in the 15%.
Mutual Funds Calculator
Monthly Investment (₹)
Expected Returns Rate (%)
Time Period (in Years)
Invested Amount
₹25,000
Estimated Returns
₹19,059
76%
Returns
Future value of your investment
₹44,059
Risk Ratios
4.77%
Standard Deviation
0.83%
Beta
0.84%
Sharpe Ratio
0.00%
Treynor's Ratio
10.65%
Jension's Alpha
Asset Allocation
Sector Allocation
Top 10 stock holding in portfolio
| Stock Invested in | % of Total Holdings | Quantity | Value (Cr) | Asset Type | Segment |
|---|---|---|---|---|---|
| Sun Pharma.Inds. | 10.72% | 330531 | 52.73 | Equity | Pharmaceuticals |
| J B Chemicals & | 9.11% | 239709 | 44.81 | Equity | Pharmaceuticals |
| Divi's Lab. | 5.48% | 44514 | 26.94 | Equity | Pharmaceuticals |
| Fortis Health. | 5.33% | 307731 | 26.20 | Equity | Healthcare |
| Lupin | 5.16% | 117818 | 25.36 | Equity | Pharmaceuticals |
| Apollo Hospitals | 4.90% | 34621 | 24.10 | Equity | Healthcare |
| Max Healthcare | 4.52% | 232215 | 22.22 | Equity | Healthcare |
| Laurus Labs | 4.41% | 224792 | 21.69 | Equity | Pharmaceuticals |
| Alkem Lab | 3.36% | 29069 | 16.50 | Equity | Pharmaceuticals |
| Krishna Institu. | 2.71% | 220599 | 13.32 | Equity | Healthcare |
Peer Comparison
| Scheme Name | Value Research | Asset Size (Cr) | 1M | 3M | 6M | 1Y | 3Y |
|---|---|---|---|---|---|---|---|
| WhiteOak Capital Pharma and Healthcare Fund-Dir (G) | 491.85 | 7.23% | -0.08% | -0.18% | 17.34% | - | |
| Nippon India Taiwan Equity Fund - Direct (G) | 448.04 | 14.06% | 31.27% | 50.42% | 93.98% | 44.11% | |
| Nippon India Taiwan Equity Fund - Direct (IDCW) | 448.04 | 14.06% | 31.27% | 50.42% | 93.98% | 44.11% | |
| HDFC Defence Fund - Direct (G) | 7793.88 | 9.07% | 3.45% | 5.90% | 46.89% | - | |
| HDFC Defence Fund - Direct (IDCW) | 7793.88 | 9.07% | 3.45% | 5.90% | 46.89% | - | |
| Franklin Asian Equity Fund - Direct (G) | 371.57 | 6.19% | 17.39% | 24.58% | 41.47% | 17.54% |
List of Schemes under WhiteOak Capital Mutual Fund
News
WhiteOak Capital Mutual Fund Change in Minimum Application Amount
WhiteOak Capital Mutual Fund ('WOCMF') / WhiteOak Capital Asset Management Limited ('WOCAMC') has decided to introduce 'Daily frequency' under SIP facility in all the existing Schemes of WOCMF effective from February 01, 2026.Scheme Name(s) Minimum amounts per instalments Minimum number of instalments SIP facility in all the existing Schemes Rs. 100/- and in multiples of Re. 1 In case of Debt Schemes, Rs. 500/- and in multiples of Re. 1
In case of WhiteOak Capital ELSS Tax Saver Fund, Rs. 500/- and in multiples of Rs. 500/-
6 Powered by Capital Market - Live News
WhiteOak Capital Mutual Fund announces change in Key Personnel
WhiteOak Capital Mutual Fund has that Mr. Avinash Sonker has been appointed as Head ' Information Technology (IT) of WhiteOak Capital Asset Management Limited effective January 01, 2026.Details of Mr. Avinash Sonker
Age: 47 years
Designation: Associate Director & Head IT
Qualification: Computer Science Engineering
Powered by Capital Market - Live News
Fund House Details & Investment Objective
Date of Incorporation
16 January 2024
Total AUM (Cr)
₹491.85
WhiteOak Capital Pharma and Healthcare Fund-Dir (G) is an Sectoral / Thematic-oriented fund from the renowned AMC, WhiteOak Capital Mutual Fund. Launched in 16 January 2024, this fund is managed by Ramesh Mantri. With assets under management (AUM) worth ₹491.85 (Cr), as of 26 February 2026, WhiteOak Capital Pharma and Healthcare Fund-Dir (G) is categorized as a Sectoral / Thematic within its segment. The fund has generated a return of 19.70% since its launch.
The current NAV of WhiteOak Capital Pharma and Healthcare Fund-Dir (G) is ₹14.59, as on 26 February 2026. The fund's benchmark index is BSE Healthcare TRI. You can invest in WhiteOak Capital Pharma and Healthcare Fund-Dir (G) via both lumpsum and SIP modes. The minimum SIP amount in the fund is ₹100 while the minimum lumpsum investment is ₹500.
Being an open-ended fund, you can exit the fund anytime subject to applicable exit loads:
The fund has generated undefined% and undefined% CAGR in the last 3 and 5 years respectively.
The fund aims to provide long-term capital appreciation and growth, by investing in a mix of financial instruments 95.29% in Equity, 2.16% in Debt and 2.55% in cash and cash equivalents.
The top 5 sectors the fund invests in are: 63.82% in Pharmaceuticals & Biotech, 24.53% in Healthcare Services, 6.37% in Debt, 2.11% in Chemicals & Petrochemical, 2.07% in Industrial Products
